- Home
- EVTC vs JANX Comparison
EVTC vs JANX Comparison
Compare EVTC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTC
- JANX
- Stock Information
- Founded
- EVTC 1988
- JANX 2017
- Country
- EVTC United States
- JANX United States
- Employees
- EVTC N/A
- JANX N/A
- Industry
- EVTC EDP Services
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- EVTC Technology
- JANX Health Care
- Exchange
- EVTC Nasdaq
- JANX Nasdaq
- Market Cap
- EVTC 2.0B
- JANX 2.2B
- IPO Year
- EVTC 2013
- JANX 2021
- Fundamental
- Price
- EVTC $35.56
- JANX $31.81
- Analyst Decision
- EVTC Hold
- JANX Strong Buy
- Analyst Count
- EVTC 3
- JANX 10
- Target Price
- EVTC $35.67
- JANX $84.00
- AVG Volume (30 Days)
- EVTC 418.1K
- JANX 898.7K
- Earning Date
- EVTC 04-30-2025
- JANX 05-06-2025
- Dividend Yield
- EVTC 0.56%
- JANX N/A
- EPS Growth
- EVTC 42.98
- JANX N/A
- EPS
- EVTC 1.73
- JANX N/A
- Revenue
- EVTC $845,486,000.00
- JANX $10,588,000.00
- Revenue This Year
- EVTC $7.85
- JANX N/A
- Revenue Next Year
- EVTC $5.39
- JANX $318.21
- P/E Ratio
- EVTC $20.82
- JANX N/A
- Revenue Growth
- EVTC 21.70
- JANX 30.99
- 52 Week Low
- EVTC $28.76
- JANX $28.92
- 52 Week High
- EVTC $40.67
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- EVTC 52.62
- JANX 39.41
- Support Level
- EVTC $36.79
- JANX $28.92
- Resistance Level
- EVTC $38.32
- JANX $31.47
- Average True Range (ATR)
- EVTC 0.96
- JANX 1.95
- MACD
- EVTC 0.02
- JANX 0.22
- Stochastic Oscillator
- EVTC 56.13
- JANX 30.42
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.